University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Enhancing Self-Management Support in Diabetes Through Patient Engagement

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Behavioral: Connection to Health (CTH)
Behavioral: Enhanced Engagement Protocol for CTH (EE-CTH)

First Posted Date: 2016-07-15

Last Posted Date: 2021-02-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 725

Registration Number: NCT02834923

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Phase 2 Efficacy Study of Primaquine and Methylene Blue

Phase 2

Completed

Conditions: Malaria

Interventions: Drug: Sulphadoxine-pyrimethamine
Drug: Dihydroartemisinin-piperaquine
Drug: Methylene blue
Drug: 0.25 mg/kg primaquine
Drug: Amodiaquine

First Posted Date: 2016-07-13

Last Posted Date: 2017-01-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT02831023

Locations: 🇲🇱
Malaria Research and Training Centre, Bamako, Mali

Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair

Phase 2

Terminated

Conditions: Infertility
Asherman's Syndrome

Interventions: Biological: Intrauterine infusion of platelet rich plasma

First Posted Date: 2016-07-07

Last Posted Date: 2021-02-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 27

Registration Number: NCT02825849

Locations: 🇺🇸
University of California San Francisco - Center for Reproductive Health, San Francisco, California, United States

Packing Versus no Packing for Cutaneous Abscess

Not Applicable

Recruiting

Conditions: Cutaneous Abscess

Interventions: Procedure: Packing
Other: No packing

First Posted Date: 2016-07-04

Last Posted Date: 2023-06-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 196

Registration Number: NCT02822768

Locations: 🇺🇸
Community Regional Medical Center, Fresno, California, United States

Evaluating the Feasibility of Disseminating a Novel Mobile Platform to Treat Depression

Not Applicable

Withdrawn

Conditions: Depression

Interventions: Behavioral: PRIME 1.0
Behavioral: PRIME 2.0

First Posted Date: 2016-06-29

Last Posted Date: 2020-01-22

Lead Sponsor: University of California, San Francisco

Registration Number: NCT02817672

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya

Not Applicable

Completed

Conditions: HIV

Interventions: Other: Shamba Maisha Intervention

First Posted Date: 2016-06-28

Last Posted Date: 2024-04-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 746

Registration Number: NCT02815579

Locations: 🇰🇪
Suna Ragana, Migori, Kenya
🇰🇪
Nyangande, Kisumu, Kenya
🇰🇪
Sindo, Suba, Homa Bay, Kenya

and more 13 locations

NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health

Not Applicable

Completed

Conditions: Premature Birth
Infections, Respiratory
Exposure to Environmental Pollution, Non-occupational
Infant, Small for Gestational Age
Fetal Growth Retardation

Interventions: Other: Low-cost gas stove
Behavioral: Peer education classes
Behavioral: Resource-intensive behavioral intervention approach

First Posted Date: 2016-06-24

Last Posted Date: 2017-10-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 50

Registration Number: NCT02812914

Locations: 🇬🇹
San Lorenzo Health Center, San Lorenzo, Guatemala

I-scan for Adenoma Detection

Not Applicable

Completed

Conditions: Colorectal Adenomatous Polyps

Interventions: Device: i-scan
Device: standard high-definition white light

First Posted Date: 2016-06-23

Last Posted Date: 2019-05-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 740

Registration Number: NCT02811419

Locations: 🇺🇸
University of California San Francisco Medical Center, San Francisco, California, United States

High-dose Erythropoietin for Asphyxia and Encephalopathy

Phase 3

Completed

Conditions: Neonatal Encephalopathy
Birth Asphyxia

Interventions: Drug: Normal saline placebo
Drug: Erythropoietin

First Posted Date: 2016-06-23

Last Posted Date: 2023-01-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 500

Registration Number: NCT02811263

Locations: 🇺🇸
Children's Hospital of San Antonio, San Antonio, Texas, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
Primary Children's Hospital, Salt Lake City, Utah, United States

and more 20 locations

Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging

Phase 4

Conditions: Peripheral Artery Disease
Vascular Disease
Critical Limb Ischemia

Interventions: Drug: Dexamethasone infusion
Device: Drug coated balloon
Device: Plain balloon angioplasty

First Posted Date: 2016-06-21

Last Posted Date: 2021-11-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 33

Registration Number: NCT02807779

Locations: 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States
🇺🇸
University of Washington, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy